Abstract
The rhizomes of Curcuma species possess pharmacological properties and produce a large number of phytochemicals, several of which have not been investigated. In the present study, non starch polysaccharides from eight Curcuma species viz. C. aeruginosa, C. amada, C. aromatica, C. brog, C. caesia, C. malabarica, C. rakthakanta and C. sylvatica were isolated and their nature and bioactivity were studied and compared with that of C. zedoaria. Non starch polysaccharides constituted about 1% of the dry weight of all the rhizomes. Arabinose, galactose, glucose, rhamnose and glucuronic acid were the major monosaccharide units. The polysaccharides exhibited both antioxidant and antiinflammatory activity. IC50(DPPH) values ranged from 4.7 - 12.5 mg, highest DPPH scavenging activity was produced by rhizome polysaccharides from C. aeruginosa, which was comparable with that of C. zedoaria (3.4 mg). All the polysaccharides exhibited high anti-inflammatory activity, some were superior to the standard drug, voveran. Bioactive polysaccharides having significant antioxidant and anti inflammatory properties can be exploited for pharmaceutical applications.
Keywords: Anti-inflammatory activity, antioxidant activity, composition; Curcuma species, non starch polysaccharides, rhizomes.
The Natural Products Journal
Title:Isolation and Evaluation of Bioactive Non Starch Polysaccharides from Eight Starchy Curcuma Species
Volume: 3 Issue: 3
Author(s): G. R. Angel, B. Vimala and Bala Nambisan
Affiliation:
Keywords: Anti-inflammatory activity, antioxidant activity, composition; Curcuma species, non starch polysaccharides, rhizomes.
Abstract: The rhizomes of Curcuma species possess pharmacological properties and produce a large number of phytochemicals, several of which have not been investigated. In the present study, non starch polysaccharides from eight Curcuma species viz. C. aeruginosa, C. amada, C. aromatica, C. brog, C. caesia, C. malabarica, C. rakthakanta and C. sylvatica were isolated and their nature and bioactivity were studied and compared with that of C. zedoaria. Non starch polysaccharides constituted about 1% of the dry weight of all the rhizomes. Arabinose, galactose, glucose, rhamnose and glucuronic acid were the major monosaccharide units. The polysaccharides exhibited both antioxidant and antiinflammatory activity. IC50(DPPH) values ranged from 4.7 - 12.5 mg, highest DPPH scavenging activity was produced by rhizome polysaccharides from C. aeruginosa, which was comparable with that of C. zedoaria (3.4 mg). All the polysaccharides exhibited high anti-inflammatory activity, some were superior to the standard drug, voveran. Bioactive polysaccharides having significant antioxidant and anti inflammatory properties can be exploited for pharmaceutical applications.
Export Options
About this article
Cite this article as:
Angel R. G., Vimala B. and Nambisan Bala, Isolation and Evaluation of Bioactive Non Starch Polysaccharides from Eight Starchy Curcuma Species, The Natural Products Journal 2013; 3 (3) . https://dx.doi.org/10.2174/22103155113039990009
DOI https://dx.doi.org/10.2174/22103155113039990009 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gene Expression Meta-Analysis of Potential Metastatic Breast Cancer Markers
Current Molecular Medicine Protein Oxidation and Proteolytic Signalling in Aging
Current Pharmaceutical Design Down-regulating Glypican-3 Expression: Molecular-targeted Therapy for Hepatocellular Carcinoma
Mini-Reviews in Medicinal Chemistry Liver Injury Associated with Antidepressants
Current Drug Safety Metabolic Syndrome, Thyroid Function and Autoimmunity - The PORMETS Study
Endocrine, Metabolic & Immune Disorders - Drug Targets RNA Splicing: Basic Aspects Underlie Antitumor Targeting
Recent Patents on Anti-Cancer Drug Discovery Phytocystatins and their Potential to Control Plant Diseases Caused by Fungi
Protein & Peptide Letters Update of Targeted Therapy-Induced Hypertension: Basics for Non-Oncology Providers
Current Hypertension Reviews Use of Antiplatelet Drugs in the Treatment of Acute Coronary Syndromes
Cardiovascular & Hematological Disorders-Drug Targets The Interaction Between Gender and Diabetes Mellitus in the Coronary Heart Disease Risk
Current Pharmaceutical Design Recent Patents for the Treatment of Asthma
Recent Patents on Inflammation & Allergy Drug Discovery PET Imaging and Coronary Circulatory Function: Non-Invasive Mechanistic Insights and Cardiovascular Prognosis
Current Cardiology Reviews Pharmaceutical Approaches for Treatment of Hepatitis C virus
Current Pharmaceutical Design Circulating Osteoclast Precursors: A Mechanism and a Marker of Erosive Arthritis
Current Rheumatology Reviews Renal Ischemia: How Commonly Does it Cause Renal Failure?
Current Hypertension Reviews Intraperitoneal Drug Therapy: An Advantage
Current Clinical Pharmacology Mechanisms and Treatment of Neuropathic Pain
Central Nervous System Agents in Medicinal Chemistry Blockade of Apoptosis by ACE Inhibitors and Angiotensin Receptor Antagonists
Current Pharmaceutical Design A Mini Review on Interactions Between Neural Stem Cells and Biomaterials
Recent Patents on Regenerative Medicine An N-terminally Truncated Mutant of Human Chemokine CXCL14 has Biological Activity
Protein & Peptide Letters